Daftar Pustaka Pre-Proposal 2

1. Martini F.H., Welch K. The Lymphatic System and Immunity. In : Fundamentals of

Anatomy and Physiology. 5th ed. New Jersey : Upper Saddle River, 2001: 132,151.
2. Savant C, Rajamani K. Tropical Diseases of the Spinal Cord. In : Critchley E, Eisen
A., editor. Spinal Cord Disease : Basic Science, Diagnosis and Management.
London : Springer-Verlag, 1997 : 378-87.
3. Tachdjian, M.O. Tuberculosis of the spine. In : Pediatric Orthopedics.2nd ed.
Philadelphia : W.B. Saunders, 1990 : 1449-54.
4. Lindsay, KW, Bone I, Callander R. Spinal Cord and Root Compresion. In :
Neurology and Neurosurgery Illustrated. 2nded. Edinburgh : Churchill Livingstone,
1991 : 388.
5. Graham JM, Kozak J. Spinal Tuberculosis. In : Hochschuler SH, Cotler HB, Guyer
RD., editor. Rehabilitation Of The Spine : Science and Practice. St. Louis : Mosby-
Year Book, Inc., 1993 : 387-90.
6. Lauerman WC, Regan M. Spine. In : Miller, editor. Review of Orthopaedics. 2nd
ed. Philadelphia : W.B. Saunders, 1996 : 270-91.
7. Currier B.L, Eismont F.J. Infections of The Spine. In : The spine. 3rd ed. Rothman
Simeone editor. Philadelphia : W.B. Sauders, 1992 : 1353-64.
8. Ombregt L, Bisschop P, ter Veer H.J, Van de Velde T. Non Mechanical Disorders
of The Lumbar Spine. In : A System of Orthopaedic Medicine.Philadelphia : W.B.
Saunders, 1995 : 615-32.
9. Natarajan M, Maxilvahanan. Tuberculosis of the spine. In: http:/www.bonetumour
org./book/APTEXT/intex.html. Book of orthopaedics and traumatoloty.
10. Miller F, Horne N, Crofton SJ. Tuberculosis in Bone and Joint. In: Clinical
Tuberculosis.2nd ed.: London: Macmillan Education Ltd, 1999 : 62-6.
11. Dlugovitzky D, Torres-Morales A, Rateni L, Farroni MA, Largacha C, Molteni O, et
al. Circulating profile of Th1 and Th2 cytokines in terculosis patients with different
degrees of pulmonary involvement. FEMS Immunol Med Microbiol.1997;18:203-7.
12. Handzel ZT, Barak V, Altman Y, Bibi H, Ligdi M, Iancovici-Kidon M,et al. Increased
Th1 and Th2 type cytokine production in patients with active tuberculosis. Isr Med
Assoc J.2007;9:479-83.
13. Salgame P. MMPs in tuberculosis: granuloma creators and tumor destroyers. J
Clin Invest. 2011;121:1686-8.
14. Heifets LB. Antimycobacterial drugs. Semin Respir Infect 1994;9:84–103.
15. Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC460
system for high-throughput screening of compounds against Mycobacterium
tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother
1997;41:1004–1009.
16. Lougheed KE, Taylor DL, Osborne SA, Bryans JS, Buxton RS. New anti-
tuberculosis agents amongst known drugs. Tuberculosis (Edinb) 2009;89:364–
370.
17. Balabanova Y, Ruddy M, Hubb J, Yates M, Malomanova N, Fedorin I, Drobniewski
F. Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of
second-line drug resistance and development of standardized therapy. Eur J Clin
Microbiol Infect Dis 2005;24: 136–139.
18. Gapski R, Hasturk H, Van Dyke TE, Oringer RJ, Wang S, Braun TM, Giannobile
WV. Systemic MMP inhibition for periodontal wound repair: results of a multi-centre
randomized-controlled clinical trial. J Clin Periodontol 2009: 36: 149-156.
19. Lindeman JH, Abdul-Hussien H, van Bockel JH, Wolterbeek R, Kleemann R.
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with
an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils
and cytotoxic T cells. Circulation 2009: 119: 2209-2216.
20. Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, Sicard GA,Thompson
RW. Preoperative treatment with doxycycline reduces aortic wall expression and
activation of matrix metalloproteinases in patients with abdominal aortic
aneurysms. J Vasc Surg 2000: 31: 325-342.
21. Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van
Hinsbergh VW, Helaakoski T, Kainulainen T, Ronka H, Tschesche H, Salo T.
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and
endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol
Chem 1997: 272: 31504-31509.
22. Smith GN, Jr., Yu LP, Jr., Brandt KD, Capello WN. Oral administration of
doxycycline reduces collagenase and gelatinase activities in extracts of human
osteoarthritic cartilage. J Rheumatol 1998: 25: 532-535.
23. Shlopov BV, Smith GN, Jr., Cole AA, Hasty KA. Differential patterns of response
to doxycycline and transforming growth factor beta1 in the down-regulation of
collagenases in osteoarthritic and normal human chondrocytes. Arthritis Rheum
1999: 42: 719-727.
24. Alvarez JI, Krishnamurthy J, Teale JM. Doxycycline treatment decreases morbidity
and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and
matrix metalloproteinase activity. Am J Pathol 2009: 175: 685-695.
25. Meli DN, Coimbra RS, Erhart DG, Loquet G, Bellac CL, Tauber MG, Neumann U,
Leib SL. Doxycycline reduces mortality and injury to the brain and cochlea in
experimental pneumococcal meningitis. Infect Immun 2006: 74: 3890-3896.
26. Krakauer T, Buckley M. Doxycycline is anti-inflammatory and inhibits
staphylococcal exotoxin-induced cytokines and chemokines. Antimicrob Agents
Chemother 2003: 47: 3630-3633.
27. WHO. Global Tuberculosis Report 2016. WHO Press. 2016.
28. Agrawal V, Patgaonkar PR, Nagariya SP. Tuberculosis of spine. Journal of
Craniovertebral Junction & Spine. 2010 Jul-Dec; 1(2): 74-85.
29. MMP-Pott Patil T, Garg RK, Jain A, Goel MM, Malhotra HS, Verma R, Singh GP,
Sharma PK. Serum and CSF Cytokines and matrix metalloproteinases in spinal
tuberculosis. Inflamm. Res. (2015) 64:97-106.
30. Kleinnijenhuis J, Joosten LAB, Van de Veerdonk FL, Savage N, Grevel RV,
Kullberg BJ, Van der Ven A, Ottenhoff THM, Dinarello CA, Van der Meer JWM,
Netea MG. Transcriptional and inflammasome-mediated pathways for the
induction of IL-1β production by Mycobacterium tuberculosis. Eur. J. Immunol.
2009. 39: 1914-1922.
31. Walker NF, Clark SO, Oni T, Andreu N, Tezera L, Singh S, Saraiva L, Pedersen B,
Kelly DL, Tree JA, D’Armiento JM, Friedland JS, Elkington PT. Doxycycline and
HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases. 2012. Am
J Respir Crit Care Med Vol. 185, Iss.9, pp989-997.
32. Rasouli MR, Mirkoohi M, Vaccaro AR, Yarandi KK, Movaghar VR. Spinal
Tuberculosis: Diagnosis and Management. 2012. Asian Spine Journal Vol. 6, No.
4, pp294-308.
33. Zhan L, Tang J, Sun M, Qin C. Animal Models for Tuberculosis in Translational
and Precision Medicine. 2017. Frontiers in Microbiology. Vol.8:717.
34. Rahyussalim AJ, Kurniawati T, Rukmana A, Fitri AD. The Potential Spread of
Mycobacterium tuberculosis into the Environment in the Creation of Spondylitis
Tuberculosis Rabbit. 2015. Advances in Ecology vol. 2015 ID 394593.
Daftar Pustaka dr. Rahyussalim

1. Go JL, Rothman S, Prosper A, Silbergleit R, Lerner A. Spine infections. Neuroimaging Clin N

Am. 2012;22(4):755-72.
2. Schlossberg, D. Tuberculosis and Non tuberculous Mycobacterial Infections. Fifth Edition,
McGraw-Hill 2006.
3. Moesbar N. Infeksi Tuberkulosa pada Tulang Belakang. Suplemen Majalah Kedokteran
Nusantara. 2006;39(3):279-89.
4. Sapardan S. Total Treatment of Tuberculosis of The Spine. A Rational Problem Solving
Approach, Perpustakaan Universitas Indonesia 2004.
5. Orme I, Juarrero MG. Animal Models of Mycobacterium tuberculosis Infection. Current
Protocol in Microbiology. John Wiley and Son Inc, 2007.
6. Bawono A. Karakteristik Spondilitis Tuberculosis di Rumah Sakit DR. Cipto Mangunkusumo
dan Rumah Sakit Fatmawati Jakarta tahun 2001-2004. Perpustakaan Universitas Indonesia, Tesis
S2.
7. Beaman, FD BL PJ, Kransdorf, J. Bone Graft Material and Synthetic Subtitutes. Radiol Clin N
Am. 2006;44:451-61.
8. Gottfried ON, Dailey AT. Mesenchymal Stem Cell and Gene therapies for Spinal Fusion.
Neurosurgery. 2008;63(3):380-91.
9. Yoon, ST, Boden, SD, Spine Fusion by Gene Therapy. Gene Therapy. 2004;11:360-7.
10. Burkus, J. K. Update : Spinal Implant Breakthrough Stabilizes Spine. Spine Universe, 2010.
http://www.spineuniverse.com/exams-tests/devices/update-spinal-implant-breakthrough-
stabilizes.
11. Poelstra KA, Barekzi NA, Grainger DW, Gristina AG, Schuler TC. A Novel Spinal Implant
Infection Model in Rabbits. Spine. 2000;25(4):406-10.
12. Ha KY, Chung YG, Ryoo SJ. Adherence and Biofilm Formation of Staphylococcus
Epidermidis and Mycobacterium Tuberculosis on Various Spinal Implants. Spine. 2004;30(1):38-
43.
13. Ofluoglu EA, Zileli M, Aydin D, Baris YS, Kucukbasmaci D, Gonullu N, et al. Implant-
related Infection Model in Rat Spine. Arch Orthop Trauma Surg. 2007;127:391-8.
14. Merino P, Candel FJ, Gestoso I, Baos E, Picazo J. Microbiological Diagnosis of Spinal
Tuberculosis. Int Orthop. 2012;36(2):233-8.
15. Nakashima T, Takayanagi H. Osteoclast and the Immune System. J Bone Miner Metab.
2009;27:519-29.

16. Debusscher F, Troussel S. Direct Repair of Defects in Lumbar Spondylolysis With a New
Pedicle Screw Hook Fixation: Clinical, Functional and Ct-assessed Study. Eur Spine J.
2007;16:1650–8.

17. Robinson Y, Tschoeke SV, Kayser R, Boehm H, Heyde C. Reconstruction of Large Defects
in Vertebral Osteomyelitis. Int Orthop. 2009;33:745-9.
18. Rosa AD, Lanza V, Tirino V, Laino L, Graziano A, Desiderio V, et al. Human Mandible
Bone Defect Repair By The Grafting of Dental Pulp Stem/Progenitor Cells and Collagen Sponge
Biocompleks. Eu Cell Mater. 2009;18:75-83.

19. Motomiya M, Ito M, Takahata M, Kadoya K, Irie K, Abum K, et al. Effect of Hydroxyapatite
Porous Characteristics on Healing Outcomes in Rabbit Posterolateral Spinal Fusion Model. Eur
Spine J. 2007;16:2215-24.

20. Bozic K, Glazer PA, Zurakowski D, Simon BJ, Lipson SJ, Hayes WC, et al. In Vivo
Evaluation of Coralline Hydroxyapatite and Direct Current Electrical Stimulation in Lumbar
Spinal Fusion. Spine. 1999; 24(20):2127-33.

21. Nather A, David V, Teng J, Lee C, Pereira B. Effect of Autologous Mesenchymal Stem Cells
on Biological Healing of Allografts in Critical-sized Tibial Defects Simulated in Adult Rabbits.
Ann Acad Med Singapore. 2010;39:599-606.

22. Nurul A, S. Boenjamin, S. Ferry. Karakteristik Biologis dan Diferensiasi Sel Punca : Fokus
pada Mesenchymal Sel Punca. Cermin Dunia Kedokteran. 2009;161(35):64-6.

23. Vats A, Tolley NS, Buttery DK, Polak JM. The Stem Cells in Orthopaedic Surgery. J Bone
Joint Surg (BR). 2004;86B(2):159-64.

24. Bilousova G, Jun DH, King KB, DeLanghe S, Chick WS, Torchia EC, et al. Osteoblasts
derived from Induced Pluripotent Stem Cells form Calcified Structures in Scaffolds both in vitro
and in vivo. Alpha Med Press. 2010;1066(5099):1-18.

25. Jilka R, Weinstein R, Bellido T, Parfitt M, Manolagas S. Osteoblast Programmed Cell Death
(Apoptosis)Modulation by Growth Factors and Cytokines. J Bone Miner Res. 1998;13(5):793-
802.

26. Thirunavukkarasu K, Halladay DL, Millest RR, Yang X, Galvin RJS, Chandrasekhar S, et al.
The Osteoblast-specific Transcription Factor Cbfa-1 Contributes to the Expression of
Osteoprotegerin, a Potent Inhibitor of Osteoclast Differentiation and Function. JBC.
2000;275(33):25163-72.

27. Schipani E, Kronenberg H. Adult Mesenchymal Stem Cells. Stembook.org.

28. Kawakami T, Kimura A, Hasegawa H, Eda S. Immunohistochemical Determination of

Osteopontin Expression in Neoplastic Cells. Oral Med Pathol. 1998;3:75-8.
165

29. Tigrani, DY and Weydert JA. Immunohistochemical Expression of Osteopontin in Epithelioid

Mesotheliomas and Reactive Mesothelial Proliferations. Am J Clin Pathol. 2007;127:580-4.
30. Kojima H, Uede T, Uemura T. In Vitro and In Vivo Effects of The Over Expression of
Osteopontin on Osteoblast Differentiation Using a Recombinant Adenoviral Vector. J Biochem.
2004:136(3);377-86.
31. Fresney R, Stacey G, Auerbach J. Culture of Human Stem Cells. Willey Interscience A John
Willey & Sons, INC, Publication.
32. Leung KS, Fung KP, Sher AH, Li CK, Lee KM. Plasma Bone-spesific Alkaline Phosphatase
as an Indicator of Osteoblastic Activity. J Bone Joint Surg Br. 1993:75(2);288-92.
33. Zhang G, Zhu B, Shi W, Wang M, Da Z, Zhang Y. Evaluation of Mycobacterial Virulence
Using Rabbit Skin Liquefaction Model. Virulence. 2010;1(3):156-63.
34. Schulz S, Steinhart H, Mutters R. Chronic Osteomyelitis in a Rabbit Model. J Inves Surg.
2001;14:121-31.
35. Bierry G, Prevest G, Mohr M, Meyer N, Dieteman JL, Kremer S, et al. Percutaneous
Inoculated Rabbit Model of Intervertebral disc space infection: Magnetic Resonance Imaging
Features with Pathological Correlation. Joint Bone Spine. 2008;75:465-70.
36. Chan JK. A Study of Osteocyte Apoptosis by Region and Quadrant in Murine Cortical Bone.
Faculty of California Polytechnic State University, San Luis Obispo 2011.
37. Tay BKB, Deckey J, Hu SS. Spinal Infections. J Am Acad Orthop Surg. 2002;10:188-97.
38. Global Tuberculosis Control, WHO Report 2010. World Health Organization.
39. Liu Y, Chen Y, Yang L, Zhou X, Wang C, Qi M, et al. The Surgical Treatment and Related
Management for Post-tubercular Kyphotic Deformity of The Cervical Spine or The Cervico-
thoracic Spine. Int Orthop. 2012;36(2):367-72
40. McLain RF, Icada C. Spinal Tuberculosis Deserves a Place on The Radar Screen. Cleve Clin
J Med. 2004;71(7):537-49.
41. Nasution A. Tuberculosis pada Ternak sebagai Zoonosis Ditinjau dari Segi Kesehatan
Masyarakat dan Kebijakan Pemerintah. Skripsi FKH IPB 2001.
42. Garg RK, Somvanshi DS. Spinal Tuberculosis: a Review. J Spinal Cord Med.
2011;34(5):440-54.
43. Smith I. Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of
Virulence. Clin Microbiol Rev. 2003;16(3):463-96.
44. Schorey JS, Carrol MC, Brown EJ. A Macrophage Invasion Mechanism of Pathogenic
Mycobacteria. Science. 1997;277(5392):1-8.
45. Dietrich J, Doherty M. Interaction of Mycobacterium tuberculosis With The Host:
Consequences for Vaccine Development. APMIS. 2009;117:440-57.
46. Zychowicz ME. Osteoarticular Manifestations of Mycobacterium tuberculosis Infection.
Orthopedic Nursing. 2010;29(6):400-6.
47. Velazquez V, Barrera D, Arenas G, Rosales C, Heiva A. Macrophage Mycobacterium
tuberculosis Interactions: Role of Complement Receptor 3. Microb Pathog. 2003;35(3):125-31.
48. Danelishvili L. McGarvey J, Li YJ, Bermudes L. Mycobacterium tuberculosis Infection
Causes Different Levels of Apoptosis and Necrosis in Human Macrophages and Alveolar
Epithelial Cells. Cell Microbiol. 2003;5(9):649-60.
49. Meghji S, White PA, Nair SP, Reddi K, Heron K, Henderson H, et al. Mycobacterium
tuberculosis Chaperonin 10 Stimulates Bone Resorption: A Potential Contributory Factor in
Pott’s Disease. J. Exp. Med. 1997;186(8):1241-6.
50. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. Bacterially Induced Bone
Destruction: Mechanism and Misconception. Infect Immun. 1996;64(7):2371-80.
51. Bierry G, Jehl F, Boehm N, Robert P, Prevost G, Dietemann JL, et al. Macrophage Activity in
Infected Areas og an Experimental Vertebral Osteomyelitis Model: USPIO-enchanced MR
Imaging Feasibility Study. Radiology. 2008;248(1):114-23.
52. Rahyussalim, Rukmana A, Ismail, Lubis AMT, Kurniawati T. New Evidence of Spondylitis
Tuberculosis : Pyogenic Microorganism or Mixed Infection? Eu Cell Mater. 2012:21 Suppl 2:72.
53. Rahyussalim, Kurniawati T, Rukmana A, Albar I, Fitri AD. The Potential Spread of
Mycobacterium tuberculosis into the Environment in the Creation of TB Spondylitis Rabbit
Models. Unpublished. . 2012
54. Nachimuthu S, Gopal LN, Alrawi S, Natesan V, Seenivasan T, Raju SK. Multicentric Spinal
Tuberculosis with a Possible Concomintant Bacterial Infection. Hosp Physic. 2000:61-66.
55. Russel G. Mycobacterium Tuberculosis: Here Today, and Here Tomorrow. Mol Cell Bio.
2001;1:1-11.
56. Furlow B. Tuberculosis: A Review an Update. Radiologic Technology. 2010;82(1):33-56.
57. Karakousis P, Bishai W, Dorman S. Mycobacterium tuberculosis Cell Envelope Lipids and
Host Immune Respond. Cell Microbiol. 2004;6(2):105-16.
58. McAdam RA, Quan S, Smith DA, Bardarov S, Betts JC, Cook FC, et al. Characterization of
a Mycobacterium tuberculosis H37RV Transposon Library Reveals Insertions in 351 ORFs and
Mutants with Altered Virulence. Microbiology. 2002;148:2975-86.
59. Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial Lipoarabinomannan and Related
Lipoglycans: From Biogenesis to Modulation of The Immune Response. Mol Microbiol.
2004;53(2):391-403.
60. Rook GAW, Seah G, Ustianowski A. M. tuberculosis: Immunology and Vaccination. Eur
Respir. 2001;17:537-57.
61. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnesi PF. T-Cell Cytokine Responses in
Human Infection with Mycobacterium tuberculosis. Infect Immun. 1995;63(8):3231-4.
62. Ernst RK, Guina T, Miuer SI. How Intracellular Bacteria Survive: Surface Modifications
That Promote Resistance to Host Innate Immune Responses. J Infect Dis. 1999;79 Suppl 2:S326-
30.
63. Dheda K, Schwander S, Zhu B, Richard N, Smit V, Zhang Y. The Immunology of
Tuberculosis: From Bench to Bedside. Respirology. 2010;15:433-50.
64. Raja A. Immunology of Tuberculosis. Indian J Med Res. 2004;120:213-32.
65. Salam A, Aditama YA, Sotoyo DK, Hudoyo A. Peranan Suplemen Vitamin A pada
Pengobatan TB. Jurnal Tuberkulosis Indonesia. 1995;4(2):6-13.
66. Kaufmann S. How Can Immunology Contribute to The Control of Tuberculosis?
Immunology. 2001;1:20-30.
67. Herman P. Biosafety Recommendations for the Contained Use of Mycobacterium tuberculosis
Complex Isolates in Industrialized Countries. Royal Library of Belgium.
68. Charles DR. Threaded Titanium Cages for Lumbar Interbody Fusions. Spine.
1997;22(6):667-79.
69. Joosten S, Meijgaarden KE, Werren PC, Kazi F, Geluk A, Savage ND, et al. Targets for
Human CD8+ T-Cells with Cytotoxic as well as Regulatory Activity. Plos Pathog. 2010;6:1-16
70. Barnes P, Wizel B. Type 1 Cytokines and the Pathogenesis of Tuberculosis. Am J Respir Crit
Care Med. 2000;161:1773-4.
71. Zhang M, Gong J, Lin Y, Barnes P. Growth of Virulent and Avirulent Mycobacterium
tuberculosis Strains in Human Macrophages. Infect Immun. 1998;66(2):794-9.
72. Manabe YC, Dannenberg AM Jr, Tyagi SK, Hatem CL, Yoder M, Woolwine SC, et al.
Different Strains of Mycobacterium tuberculosis Cause Various Spectrums of Disease in the
Rabbit Model of Tuberculosis. Infect Immun. 2003;71(10):6004-11.
73. Tsenova L, Harbacheuski R, Ellison E, Manca C, Kaplan G. Aerosol Exposure System for
Rabbits: Application to M. Tuberculosis Infection. Applied Biosafety. 2006;11(1):7-14.

74. Converse P, Dannenberg AM, Estep JE, Sugisaki K, Abe Y, Shofield BM, et al. Cavitary
Tuberculosis Produced in Rabbits by Aerosolized Virulent Tubercle Bacilli. Infect Immun.
1996;64(11):4776-87.

75. Zhang G, Zhu B, Shi W, Wang M, Da Z, Zhang Y, et al. Evaluation of Mycobacterial

Virulence Using Rabbit Skin Liquefaction Model. Virulence. 2010;1(3):156-63.

76. Pearce A, Richards RG, Milz S, Schneider E, Pearce SG. Animal Models for Implant
Biomaterial Research in Bone : A Review. Eu Cell Mater. 2007;13:1-10.

77. Dontas IA, Marinou KA, Iliopoulos D, Tsantila N, Agrogiannis G, Papalouis A, et al.
Changes of Blood Biochemistry in The Rabbit Animal Model in Atherosclerosis Research; A
Time or Stress-effect. Lipids in Health and Disease. 2011;10(139):1-6.

78. Candeda R, Giannoni P. A Tissue Engineering Approach to Bone Repair in Large Animal
Models and in Clinical Practice. Tissue Engineering Concept Encyclopedia of Materials. Science
and Technology. 2001:9358-9361.

79. Infectious Diseases in Rabbits.

http://www.mercerandhughes.co.uk/index.php?option=com_content.
80. Wang J, Wan R, Mo Y, Zhang Q, Sherwood LC, Chien S, et al. Creating a Long-Term
Diabetic Rabbit Model. Exp Diabetes Res. 2010 Article ID 289614.

81. Kobayashi T, Ito T, Shiomin M. Roles of the WHHL Rabbit in Translational Research on
Hypercholesterolemia and Cardiovascular Diseases. J Biomed Biotechnol. 2011 Article ID
406473.

82. Wang W, Xu R, Li J. Production of Native Bispecific Antibodies in Rabbits. Plos One

.2010;5:1-8.

83. Cheng X, Lei D, Mao T, Yang S, Chen F, Wu W, et al. Repair of Critical Bone Defects With
Injectable Platelet Rich Plasma/Bone Marrow Derived Stromal Cells Composite: Experimental
Study in Rabbits. TJTES. 2008;14(2):87-95.

84. Sah R, Ratcliffe A. Translational Models for Musculoskeletal Tissue Engineering and
Regenerative Medicine. Tissue Eng. 2010;16(1):1-4.
85. Fisher JP, Vehof JW, Dean D, van der Waerden JP, Holland TA, Mikos AG, et al. Soft and
Hard Tissue Respone to Photocrosslinked Poly (Propylene Fumarate) Scaffolds in Rabbit Model.
J Bio Mat Res. 2002;59(3):547-56.
86. Komatsu M. Penetration of Linezolid Into Rabbit Intervertebral Discs and Surrounding
Tissues. Eur Spine J. 2010;19:2149–55.
87. Variation of Animals and Plants.

http://www.europeanamericansunited.org/school1/Darwin/book/content.
88. Ordway D, Henao TM, Smith E, Shanley C, Harton M, Troudt J, et al. Animal model of
Mycobacterium Abscessus Lung Infection. J Leu Biol. 2008;83(6):1502-11.
89. Capuano SV, Croix DA, Pawar S, Zinovik A, Myers A, Lin P, et al. Experimental
Mycobacterium tuberculosis Infection of Cynomolgus Macaques Closely Resembles the Various
Manifestations of Human M. tuberculosis Infection. Infect Immun. 2003;7(10):5831-44.
90. Basaraba RJ. Experimental Tuberculosis: The Role of Comparative Pathology in The
Discovery of Improved Tuberculosis Treatment Strategies. Tuberculosis. 2008;88 Suppl 1:S35-
S47.
91. UFAW. The UFAW Handbook on the Care & Management of Laboratory Animal. UK Bath
Press, Avon, 1987.
92. Boskey AL, Coleman R. Aging and Bone. J Dent Res. 2010;89(12):1333-48.
93. Matsuo K, Otaki N. Bone Cell Interactions Through Epinephrin: Bone Modeling, Remodeling
and Associated Diseases. Cell Adh Migr. 2012 ;6(2):148-56.
94. Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T, et al. MicroRNA Control of
Bone Formation and Homeostasis. Nat Rev Endocrinol. 2012;8(4):212-27.
95. Kohsla S, Westendorf J, Oursler M. Building Bone to Reserve Osteoporosis and Repair
Fractures. J Clin Invest. 2008;118(2):421-8.
96. Marriot I, Rati DM, McCall SH, Tranguch S. Osteoblasts Following Bacterial Challenge
Pattern Recognition Receptors in Murine Induction of Nod1 and Nod2 Intracellular. Infect
Immun. 2005;73(5):2967-73.
97. Gasper NA, Petty CC, Schrum LW, Marriott I, Bost KL. Bacterium Induced CXCL10
Secretion by Osteoblast can be Mediated in Part Through Tolls-like-receptor 4. Infect Immun.
2002;70(8):4075-82.
98. Fernandez MAS, Gallois A, Riedl T, Jurdic P, Hoflack B. Osteoclast Control Osteoblast
Chemotaxis via PDGF-BB/PDGF Receptor Beta Signaling. Plos One. 2008;3:1-8.

99. Leonardi E, Ciapetti G, Beglia SR, Devescovi V, Baldini N, Granchi D, et al. Osteogenic
Properties of Late Adherent Sub Populations of Human Bone Marrow Stromal Cells. Histochem
Cell Biol. 2009;132:547-57.
100. Liao SS, Guan K, Cui FZ, Shi SS, Sun TS. Lumbar Spinal Fusion with a Mineralized
Collagen Matrix and rhBMP-2 in a Rabbit Model. Spine.2008:28(17);1954-60.
101. Stock U, Vacanti J. Tissue Engineering: Current State and Prospects. Annu Rev Med.
2001;52:443–51.
102. Teixeira S, Oliveira SM, Ferraz MP, Monteiro FJ. Three Dimensional Macroporous
Calcium Phosphate Scaffolds for Bone Tissue Engineering. Key Engineering Material.
2007;20;361-3.
103. Farrell E, O'Brien FJ, Doyle P, Fischer J, Yannas I, Harley BA, et al. A Collagen-
glycosaminoglycan Scaffold Supports Adult Rat Mesenchymal Stem Cell Differentiation Along
Osteogenic and Chondrogenic Routes. Tissue Eng. 2006;12(3):459-68.
104. Kassem M, Kristiansen M, Abdallah B. Mesenchymal Stem Cells: Cell Biology and
Potential Use in Therapy. Basic Clin Pharmacol Toxicol. 2004;95:209-14.
105. Bourin P, Gadelorge M, Peyrafitte JA, Fleury CS, Gomez M, Rage C. Mesenchymal
Progenitor Cells: Tissue Origin, Isolation and Culture. Transfus Med Hemother. 2008;35:160-7.
106. Koç ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W, et al. Allogeneic
Mesenchymal Stem Cell Infusion for Treatment of Metachromatic Leukodystrophy (MLD) and
Hurler Syndrome (MPS-IH). Bone Marrow Transplant. 2002:30;215–22.
107. Bang OY, Lee JS, Lee PH, Lee G. Autologous Mesenchymal Stem Cell Transplantation in
Stroke Patients. Ann Neurol. 2005:57(6);874-82.
108. Franco NH, Correia-Neves M, Olsson IA. Animal Welfare in Studies on Murine
Tuberculosis : Assessing Progress Over a 12-year Period and The Need for Further
Improvement. PLoS One. 2012;7(10):e47723.
109. Caplan A. Mesenchymal Stem Cells: Cell-Based Reconstructive Therapy in Orthopedics.
Tissue Eng. 2005;22:7-8.
110. Caplan A. Adult Mesenchymal Stem Cells for Tissue Engineering Versus Regenerative
Medicine. J. Cell. Physiol. 2007;213:341–7.
111. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal
Stem Cell Engraftment in Lung is Enhanced in Response to Bleomycin Exposure and Ameliorates
its Fibrotic Effects. Proceedings of the National Academy of Science of The United State of
America. 2003;100(14):8407-11.

112. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, et al. Mesenchymal Stem
Cells Modified with Akt Prevent Remodeling and Restore Performance of Infarcted Hearts. Nat
Med. 2003;9(9):1195-201.
113. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, et al. Clinical
Responses to Bone Marrow Transplantation in Children With Severe Osteogenesis Imperfect.
Blood. 2001:97;1227-31.
114. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G, et al.
Mesenchymal Stem Cells Contribute to Renal Repair of Acute Tubular Epithelial Injury. Int J
Mol Med. 2004;14(6):1035-41.
115. Lucarelli E, Fini M, Beccheroni A, Giavaresi G, Di Bella C, Aldini NN, et al. Stromal Stem
Cells and Platelet-Rich Plasma Improve Bone Allograft Integration. Clin Orthop Relat Res.
2005:435:62-8.
116. Banerjee C, Javed A, Choi JY, Green J, Rosen V, Van Wijnen AJ, et al. Differential
Regulation of the Two Principal Runx2/Cbfa1 N-Terminal Isoforms in Response to Bone
Morphogenetic Protein-2 during Development of the Osteoblast Phenotype. Endocrinology.
2001;142(9):4026-39.
117. Li Pira G, Ivaldi F, Bottone L, Quarto R, Manca F. Human Bone Marrow Stromal Cells
Hamper Specific Interaction of CD3 and CD8 T Lymphocytes with Antigen-Presenting Cells.
Hum Immunol. 2006:67(12);976-85.
118. Mei SH, Haitsma JJ, Dos santos CC, Deng Y, Lai PF, Slutsky AS, et al. Mesenchymal Stem
Cells Reduce Inflammation while Enchanching Bacterial Clearance and Improving Survival in
Sepsis. Am J Respir Crit Care Med. 2010;182:1047-57.
119. Ramesh Chandra Rai, Debapriya Bhattacharya and Gorbadan Das. Stem Cells in Infection
Diseases. Insight and Control of Infection Disease in Global Scenario. Intech ISBN. 978-953-51-
0319-6.
120. George J, Kuboki Y, Miyata T. Differentiation of Mesenchymal Stem Cells Into Osteoblasts
on Honeycomb Collagen Scaffolds. Biotechnology and Bioengineering. 2006;10:404-11
121. Barbieri EJ, Ciaccio EI. Depression of Drug Metabolism in The Mouse by A Combination of
Mycobacterium butyricum and Anaesthetics. Br. J. Pharmac. 1979;65:111-5.
122. Callis AH, Brooks SD, Roth TP, Gandolfi AJ, Brown BR. Characterization of a Halothane-
Induced Humoral Immune Response in Rabbits. Clin. exp. Immunol. 1987;67:343-51.
123. Nakayama J, Fujioka H, Nagura I, Kokubu T, Makino T, Kuroda R, et al. The Effect of
Fibroblast Growth Factor-2 on Autologous Osteochondral Transplantation. Int Orthop.
2009;33:275-80.

124. Sugawara I, Yamada H, Mizuno S. Nude rat (F344/N-rnu) tuberculosis. Cell Microbiol.
2006;8(4):661-7.
125. Lu R, Ashwell KW, Waite P. Advances in Secondary Spinal Cord Injury. Role of Apoptosis.
Spine. 2000;25(14):1859-66.
126. Lisignoli G. Hyaluronan-Based Polymer Scaffold Modulates the Expression of Inflammatory
and Degradative Factors in Mesenchymal Stem Cells: Involvement of Cd44 and Cd54. J Cell
Physiol. 2006;201:364-73.
127. Zumarraga M, Bigi F, Alito A, Romano MI, Cataldi A. A 12.7 kb fragment of the
Mycobacterium tuberculosis Genome is not Present in Mycobacterium bovis. Microbiology.
1999;145:893-7.
128. Naderi MM, Sarvari A, Milanifar A, Boroujeni SB, Akhondi MM. Regulations and Ethical
Considerations in Animal Experiments: International Laws and Islamic Perspectives. Avicenna J
Med Biotechnol. 2012;4(3):114-20.
129. Scheman L, Janota M, Lewin P. The Production of Experimental Osteomyelitis, Preliminary
Report. J Am Med Assoc. 1941;117:1525–9.
130. Andriole VT, Nagel DA, Southwick WO. A Paradigm for Human Chronic Osteomyelitis. J
Bone Joint Surg. 1973;55A:1511–5
131. Al-Attiyah RJ, Mustafa AS. Mycobacterial Antigen-Induced T Helper Type 1 (Th1) and Th2
Reactivity of Peripheral Blood Mononuclear Cells from Diabetic and Non-Diabetic Tuberculosis
Patients and Mycobacterium bovis Bacilli Calmette-Guerin (BCG)-Vaccinated Healthy Subjects.
Clin Exp Immunol. 2009;158(1):64-73.
132. Norden CW, Kennedy E. Experimental Osteomyelitis I. A Description of The Model. J Infect
Dis. 1970;122:410-8.
133. Capuano SV 3rd, Croix DA, Pawar S, Zinovik A, Myers A, Lin PL, Bissel, et al.
Experimental Mycobacterium tuberculosis Infection of Cynomolgus Macaques Closely Resembles
the Various Manifestations of Human M. tuberculosis Infection. Infect Immun. 2003;7(10):5831-
44.
134. Manabe YC, Dannenberg AM Jr, Tyagi SK, Hatem CL, Yoder M, Woolwine SC, et al.
Different Strains of Mycobacterium tuberculosis Cause Various Spectrums of Disease in the
Rabbit Model of Tuberculosis. Infect Immun. 2003;71(10):6004-11.
135. Sekhon LHS, Fehlings MG. Epidemiology, Demographics, and Pathophysiology of Acute
Spinal Cord Injury. Spine. 2001;26(24S):S2-S12.
136. Jain AK, Kumar J. Tuberculosis of Spine: Neurological Deficit. Eur Spine J. 2012:2335-7.
137. Colmenero JD, Morata P, Ruiz-Mesa JD, Bautista D, Bermúdez P, Bravo MJ, et al.
Multiplex Real-Time Polymerase Chain Reaction A Practical
Approach for Rapid Diagnosis of Tuberculous and Brucellar Vertebral Osteomyelitis. Spine.
2010;35(24):E1392-E1396.

138. Ziv Y, Avidan H, Pluchino S, Martino G, Schwartz M. Synergy Between Immune Cells and
Adult Neural Stem Progenitor Cells Promotes Functional Recovery from Spinal Cord Injury.
PNAS. 2006;103(35):13174-79.
139. Tuli SM. Historical Aspects of Pott’s Disease (Spinal Tuberculosis) Management. Eur Spine
J. 2012:2388-97.
140. Cavalcanti YVN, Brelaz MCA, Neves JKAL, Ferraz JC, Pereira VRA. Role of TNF-Alpha,
IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis. Pulm Med.
2012;745483:1-10.
141. Lian H, Shim DJ, Gaddam SS, Rodriguez-Rivera J, Bitner BR, Pautler RG, et al. IκBα
Deficiency in Brain Leads to Elevated Basal Neuroinflammation and Attenuated Response
Following Traumatic Brain Injury: Implications for Functional Recovery. Mol Neurodegener.
2012;7:47.
142. Jimenez RS, Colmenero JD, Bermudez P, Alonso A, Morata. Amplicon DNA Melting
Analysis for The Simultaneous Detection of Brucella spp and Mycobacterium tuberculosis
Complex, Potential use in Rapid Differential Diagnosis Between Extrapulmonary tuberculosis
and Focal Complications of Brucellosis. Plos One. 2013;8(3):1-9.
143. Solis AH, Gonzales NEH, Cazarez F, Perez MP, Diaz HO, Gitierrez E, et al. Skin Biopsy : A
Pillar in The Identification of Cutaneous Mycobacterium tuberculosis infection. J Infect Dev
Ctries. 2012;6(8):626-31.
144. Lindeboom JA, Coppenraet LAB, Soolingen D, Prins JM, Kuijper EJ. Clinical
Manifestations, Diagnosis, and Treatment of Mycobacterium Haemophilum Infections. Clin
Microbiol Rev. 2011;24(4):701-17.
145. Hunter RL. Pathology of Post Primary Tuberculosis of The Lung: an Illustrated Critical
Review. Tuberculosis (edinb). 2011;91(6):497-509.
146. Kaplan G, Post FA, Moreira AL, Wainwright H, Kreiswirth BN, Tanverdi M, et al.
Mycobacterium tuberculosis Growth at the Cavity Surface: a Micro-environment with Failed
Immunity. Infect Immun. 2003; 71(12):7099-108.
147. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The Relative Importance of T Cell
Subsets in Immunity and Immunopathology of Airborne Mycobacterium tuberculosis Infection in
Mice. J. Exp. Med. 2001;193(3):271-80.
148. Russel DG. Mycobacterium tuberculosis and The Intimate Discourse of a Chronic Infection.
Immunol Rev. 2011;240(1):252-68.
149. Handzel ZT, Barak V, Altman Y, Bibi H, Lidgi M, Iancovici-Kidon M, et al. Increased Th1
and Th2 Type Cytokine Production in Patiens with Active Tuberculosis. Isr Med Assoc J.
2007;9(6):479-83.

150. Rasouli MR, Mirkoohi M, Vaccaro AR, Yarandi KK, Rahimi-Movaghar V. Spinal
Tuberculosis : Diagnosis and Management. Asian Spine J. 2012:6(4);294-308.
151. Gerometta A, Bittan F, Rodriguez Olaverri JC. Postoperative Spondilodiscitis. Int Orthop.
2012;36(2):433-8.
152. Cao JJ. Effects of Obesity on Bone Metabolism. J Orthop Surg Res. 2011;6(30):1-7.
153. Madhira SL, Challa SS, Chalasani M, Nappanveethl G, Bhonde RR, Ajumeera R. et al.
Promise(s) of Mesenchymal Stem Cells as an In Vitro Model System to Depict Pre-
diabetic/diabetic Milieu in WNIN/GR-Ob Mutant Rats. PLoS One. 2012;7(10):1-13.
154. Thomas MV, Puleo DA. Infection, Inflammation, and Bone Regeneration: a Paradoxical
Relationship. J Dent Res. 2011;90(9):1052-61.
155. Koning JJ, Kooij G, de Vries HE, Nolte MA, Mebius RE. Mesenchymal Stem Cells Are
Mobilized from The Bone Marrow During Inflammation. Front Immunol. 2013;4(49):1-11.
156. Kim JW, Lee JH, Lyoo YS, Jung DI, Park HM. The Effects of Topical Mesenchymal Stem
Cell Transplantation in Canine Experimental Cutaneous Wounds. Vet Dermatol. 2013;24(2):242-
53.
157. Li J, Li D, Liu X, Tang S, Wei F. Human Umbilical Cord Mesenchymal Stem Cells Reduce
Systemic Inflammation and Attenuate LPS-induced Acute Lung Injury in Rats. J Inflamm (Lond).
2012;9(1):1-11.
158. Moriishi T, Fukuyama R, Ito M, Miyazaki T, Maeno T, Kawai Y, et al. Osteocyte Network;
a Negative Regulatory System for Bone Mass Augmented by The Induction of Rankl in
Osteoblasts and Sost in Osteocytes at Unloading. PLoS One. 2012;7(6):1-20.
159. Karlsson H, Samarasinghe S, Ball LM, Sundberg B, Lankester AC, Dazzi F, et al.
Mesenchymal Stem Cells Exert Differential Effects on Alloantigen and Virus-specific T-cell
Responses. Blood. 2008;112(3):532-41.
160. Ni P, Fu S, Fan M, Guo G, Shi S, Peng J, et al. Preparation of Poly(ethylene
glycol)/polylactide Hybrid Fibrous Scaffolds for Bone Tissue Engineering. Int J Nanomedicine.
2011;6:3065-75.
161. Thomas MV, Puleo DA. Infection, Inflammation, and Bone Regeneration: a Paradoxical
Relationship. J Dent Res. 2011;90(9):1052-61.
162. Dimitriou R, Mataliotakis GI, Calori GM, Giannoudis PV. The Role of Barrier Membranes
for Guided Bone Regeneration and Restoration of Large Bone Defects: Current Experimental
and Clinical Evidence. BMC Med. 2012; 10(81):1-24.

163. Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM. Osteogenic
Differentiation of Mesenchymal Stem Cells is Regulated by Osteocyte and Osteoblast Cells in a
Simplified Bone Niche. Eur Cell Mater. 2012;23:13-27.
164. Martina JD, Simmons C, Jukic DM. High-definition Hematoxylin and Eosin Staining in a
Transition to Digital Pathology. J Pathol Inform. 2011;2:45.
165. Neman J, Hambrecht A, Cadry C, Jandial R. Stem Cell-Mediated Osteogenesis: Therapeutic
Potential for Bone Tissue Engineering. Biologics. 2012;6:47-57.
166. Tracy RP, Doyle MF, Olson NC, Huber SA, Jenny NS, Sallam R, et al. T-helper Type 1 Bias
in Healthy People is Associated with Cytomegalovirus Serology and Atherosclerosis: The Multi-
ethnic Study of Atherosclerosis. J Am Heart Assoc. 2013;2(3):1-13.
167. Chang CY, Hong JY, Yuan MK, Chang SJ, Lee YM, Chang SC, et al. Risk Factors in
Patients with AFB Smear-Positive Sputum who Receive Inappropriate Antituberculous
Treatment. Drug Des Devel Ther. 2013;7:53-8.
168. Kamal AF. Transplantasi Sel Punca Mesenkimal, Recombinant Human BMP-2, dan
Kombinasinya Dalam Percepatan Union Osteotomi dan Peningkatan Kekuatan Mekanik
Autograft Femur yang Mendapat Pajanan Extracorporeal Irradiation pada Model Tikus.
Fakultas Kedokteran Universitas Indonesia. Disertasi S3. 2012.